255 related articles for article (PubMed ID: 31738908)
21. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
Peng Y; Fang X; Yao H; Zhang Y; Shi J
Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
[No Abstract] [Full Text] [Related]
22. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
23. MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.
Chen J; Yin J; Liu J; Zhu RX; Zheng Y; Wang XL
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1145-1150. PubMed ID: 30779083
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.
Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S
J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771
[TBL] [Abstract][Full Text] [Related]
25. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
Sun Y; Zhang L; Zhang S
Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
[TBL] [Abstract][Full Text] [Related]
26. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
Wang R; Zhao L; Ji L; Bai L; Wen Q
Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
[TBL] [Abstract][Full Text] [Related]
27. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
Xue KC; Hu DD; Zhao L; Li N; Shen HY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
[TBL] [Abstract][Full Text] [Related]
28. MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD.
Zhu J; Zhang Q; Jin XY; Cai JB; Chen X; Shi WB; Pang WY; Guo GL; Yang LJ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2856-2862. PubMed ID: 31002136
[TBL] [Abstract][Full Text] [Related]
29. miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma.
Ren L; Xu Y; Qin G; Liu C; Yan Y; Zhang H
IUBMB Life; 2019 Jan; 71(1):28-40. PubMed ID: 30325582
[TBL] [Abstract][Full Text] [Related]
30. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
[TBL] [Abstract][Full Text] [Related]
31. Circ-LDLRAD3/miR-655-3p/MAPK1 axis enhances cell migration and invasion in papillary thyroid carcinoma.
Zhang B; Peng Y; Zhou L
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):150-155. PubMed ID: 38430029
[TBL] [Abstract][Full Text] [Related]
32. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
33. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10.
Liu F; Lou K; Zhao X; Zhang J; Chen W; Qian Y; Zhao Y; Zhu Y; Zhang Y
Int J Mol Med; 2018 Dec; 42(6):3027-3036. PubMed ID: 30272290
[TBL] [Abstract][Full Text] [Related]
34. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
[TBL] [Abstract][Full Text] [Related]
35. miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas.
Xie Z; Chen W; Chen Y; Wang X; Gao W; Liu Y
Int J Oncol; 2017 Nov; 51(5):1574-1582. PubMed ID: 29048613
[TBL] [Abstract][Full Text] [Related]
36. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
Zhao Y; Zhao L; Li J; Zhong L
J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
39. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
Cao XZ; Bin H; Zang ZN
Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
[TBL] [Abstract][Full Text] [Related]
40. Sevoflurane inhibits the progression of PTC by downregulating miR-155.
Li Y; Zeng QG; Qiu JL; Pang T; Wang H; Zhang XX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6579-6587. PubMed ID: 31378899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
